http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2015536315-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-06 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-713 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7105 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7088 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K19-00 |
| filingDate | 2013-10-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2015-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2015536315-A |
| titleOfInvention | Compositions and methods for drug delivery |
| abstract | The present invention relates to compositions and methods suitable for delivering molecules to mammals. The invention particularly relates to peptide derivatives (peptides and pseudopeptides), dimers or multimers thereof, and their use as vectors for molecules of interest. The present invention also relates to a conjugate containing a peptide derivative of the present invention or a dimer or multimer thereof linked to a molecule of interest. The peptides of the present invention can be used in various ways, particularly through specific receptors (receptor-mediated transport, RMT), generally in the form of prodrug conjugates, healthy or pathological (cancer cells) To vectorize molecules of pharmaceutical or diagnostic interest, such as therapeutic molecules, imaging agents or diagnostic agents or molecular probes, which cross the cell membrane of tissues or organs (eg liver, adrenal glands and intestines) and especially It can be used to allow its transport across the physiological barriers of the nervous system such as the blood brain barrier (BBB), the cerebrospinal barrier (BSCB) or the blood retinal barrier (BRB). |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2020506921-A |
| priorityDate | 2012-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 402.